Botanical species · safety record

Calotropis gigantea

The EFSA Compendium of Botanicals holds 13 constituent measurements and 1 adverse-effect record for Calotropis gigantea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Calotropis gigantea (L.) W.T.Ait.

13Constituent measurements
1Safety records
7Cited sources
11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Calotropis gigantea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Root

What the records describe

Constituents measured

  • Cardenolides2
  • Cardiac glycosides2
  • Saponins2
  • Alkaloids1
  • Calcium oxalate1
  • Calotropin1
  • Coumarins1
  • Frugosides1
  • Lignans1
  • Tannins1

Plant parts

  • Leaves7
  • Roots and other underground parts3
  • Aerial part of plants2
  • Stem2
  • stalk2

Preparations

  • Solvent extraction14

Effect types

  • Reproductive1

Target tissues

  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extraction—Phytochemical screeningResolve DOI
Calcium oxalateAerial part of plantsSolvent extraction1 PercentUnspecifiedResolve DOI
CardenolidesLeavesSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Cardiac glycosidesLeavesSolvent extraction—Phytochemical screeningResolve DOI
Cardiac glycosidesAerial part of plantsSolvent extraction—UnspecifiedResolve DOI
CoumarinsStem / stalkSolvent extraction—Phytochemical screeningResolve DOI
LignansLeavesSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
SaponinsLeavesSolvent extraction—Phytochemical screeningResolve DOI
SaponinsStem / stalkSolvent extraction—Phytochemical screeningResolve DOI
TanninsLeavesSolvent extraction—Phytochemical screeningResolve DOI
CalotropinRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
CardenolidesLeavesSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
FrugosidesRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusRoots and other underground partsSolvent extractionRat (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Srivastava, Shobha Rani., Keshri, Govind., Bhargavan, Biju., Singh, Chandan., Singh, Man Mohan. Pregnancy interceptive activity of the roots of Calotropis gigantea Linn. in rats . Contraception, 2007, vol. 75, no. 4, p. 318-322. DOI
  2. Lhinhatrakool, Thitima., Sutthivaiyakit, Somyote. 19-Nor- and 18,20-epoxy-cardenolides from the leaves of Calotropis gigantea . Journal of natural products, 2006, vol. 69, no. 8, p. 1249-1251. DOI
  3. Kiuchi, F., Fukao, Y., Maruyama, T., Obata, T., Tanaka, M., Sasaki, T., Mikage, M., Haque, ME., Tsuda, Y. Cytotoxic principles of a Bangladeshi crude drug, akond mul (roots of Calotropis gigantea L.) . Chemical & pharmaceutical bulletin, 1998, vol. 46, no. 3, p. 528-530.
  4. Ghule, S.D., Vidyasagar, G., Bhandari, A., Sharma, P., Gunjal, A.P. CNS activity of leaves extract of Calotropis gigantea. Asian pacific journal of tropical disease, 2014, vol. 4, no. S2, p. S902-S905. DOI
  5. Hasballah, K., Murniana., Erya., Ardian. Cytotoxic bioactive compounds from calotropis gigantea stem bark. International journal of pharmacy and pharmaceutical sciences, 2016, vol. 8, no. 9, p. 111-115. DOI
  6. Seeka, Chonticha., Sutthivaiyakit, Somyote. Cytotoxic Cardenolides from the Leaves of Calotropis gigantea. Chemical & pharmaceutical bulletin, 2010, vol. 58, no. 5, p. 725-728.
  7. Murti, P.B.R., Seshadri, T.R. Chemical composition of Calotropis gigantea - Part I. Wax and resin components of the latex. Proceedings of the indian academy of sciences - section a, 1943, vol. 18, no. 3, p. 145-159. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue